NEWS
HOPE BTK registry reinforced the safety and efficacy of the company’s MagicTouch percutaneous transluminal angioplasty (PTA) sirolimus-coated balloon for treatment of below-the-knee (BTK) lesions.
Concept Medical (MagicTouch PTA 0.035 OTW) receives CE Mark for treatment of peripheral artery disease.
AWARDS
Concept Medical has officially been ranked among India’s Great Mid-size Workplaces 2025
Concept Medical Wins Times Healthcare Leaders 2025 awards for Innovation Excellence
Envisionscientific has achieved the prestigious ESG (Environmental, Social, and Governance) Certification!
PRESS RELEASE
17/01/2026
Concept Medical Announces First Patient Enrollment In Stars DAPT Randomized Clinical Trial Evaluating Abluminus Np Polymer-Free Des
24/11/2025
Concept Medical Group earns Great Place to Work® certification for the second consecutive year
12/09/2025
ANVISA Grants Commercial Approval to Concept Medical’s MagicTouch Sirolimus-Coated Balloon for CAD in Brazil
05/09/2025
Sirolimus Coated Balloon Associated with Superior 3-Year Outcomes Against POBA: Insights from The Hope BTK Registry